{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04149743",
            "orgStudyIdInfo": {
                "id": "20192767/HT-17-VV-020"
            },
            "secondaryIdInfos": [
                {
                    "id": "1R44HL145941",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1R44HL145941"
                }
            ],
            "organization": {
                "fullName": "Aventusoft, LLC.",
                "class": "INDUSTRY"
            },
            "briefTitle": "HEMOTAG\u00ae Assessment for Short-term Outcomes of Heart Failure",
            "officialTitle": "HEMOTAG\u00ae Assessment for Short-term Outcomes of Heart Failure [HATS-OFF]",
            "acronym": "HATS-OFF",
            "therapeuticArea": [
                "Cardiovascular"
            ],
            "study": "hemotag-assessment-for-short-term-outcomes-of-heart-failure"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-01-31",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-10-29",
            "studyFirstSubmitQcDate": "2019-10-31",
            "studyFirstPostDateStruct": {
                "date": "2019-11-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-08-11",
            "lastUpdatePostDateStruct": {
                "date": "2023-08-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Aventusoft, LLC.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "National Heart, Lung, and Blood Institute (NHLBI)",
                    "class": "NIH"
                },
                {
                    "name": "Cleveland Clinic Florida",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "Evaluation of the HEMOTAG\u00ae system in a less controlled environment and concurrently develop the system for use by patients with heart failure.",
            "detailedDescription": "The overall objective of research is to test, adapt, refine and validate the HEMOTAG\u00ae system to be used outside the usual medical care environments to reduce hospital readmissions."
        },
        "conditionsModule": {
            "conditions": [
                "Heart Failure (HF)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "PARTICIPANT"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 420,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Randomized Standard of Care",
                    "type": "NO_INTERVENTION",
                    "description": "Standard of Care"
                },
                {
                    "label": "Randomized Standard of Care with HEMOTAG",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Standard of Care with HEMOTAG",
                    "interventionNames": [
                        "Diagnostic Test: Standard of Care with Hemotag"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Standard of Care with Hemotag",
                    "description": "Comparison of outcomes",
                    "armGroupLabels": [
                        "Randomized Standard of Care with HEMOTAG"
                    ],
                    "otherNames": [
                        "Standard of Care"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "The number of recurrent HF readmissions. [Monitoring period: 30 days]",
                    "description": "Determine if HEMOTAG can reduce the relative number of HF readmissions or ER visits versus standard of care. \\[Monitoring period: 30 days from time of participant's discharge from initial index hospitalization\\]",
                    "timeFrame": "30 Days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Time from discharge until the first event of HF readmissions [Monitoring period: Event time assessed up to 3 months and 6 months from discharge.",
                    "description": "Time from discharge to the first event of HF readmissions or ER visits \\[Monitoring period:\n\nEvent time assessed up to 3 months and 6 months from time of participant's discharge from initial study hospitalization.\\]",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Number of total days lost to hospitalization due to HF events [Monitoring period: Expected average of 30 days, 3 months, 6 months]",
                    "description": "Total number of total days lost to hospitalization or ER visit due to HF events \\[Monitoring period: Expected average of 30 days, 3 months, 6 months from time of participant's discharge from index hospitalization.\\]",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Time from discharge to all-cause mortality [Monitoring period: 30 days, 3 months,6 months]",
                    "description": "Time from discharge to all-cause mortality \\[Monitoring period: 30 days, 3 months,6 months from time of participant's discharge from initial study hospitalization.\\]",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Skin irritation from HEMOTAG use [Time Frame: over the measurement period of 30 days] (Determine if subjects had skin irritation from use.)",
                    "description": "Incidence of skin irritation \\[Time Frame: over the measurement period of 30 days\\] (Determine if subjects had skin irritation from use of device.)",
                    "timeFrame": "30 Days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age greater than or equal to 22 years old.\n* An index hospital admission for ADHF presenting with symptoms, clinical signs, and chest x-ray (CXR) findings of pulmonary congestion, receiving IV diuretics or vasoactive drugs and having a BNP \\> 350 or NT-pro BNP \\> 1800 pg/ml.\n* Able to give informed consent.\n* Participant's residence has adequate cellular data coverage.\n* Participants with previous diagnosis of left ventricular ejection fraction (LVEF) \\<40% prior to the index hospitalization must have been treated for at least 90 days prior to enrollment with diuretics and beta-blocker (unless intolerant or contraindicated) and an ACE inhibitor or ARB or ARNi (unless intolerant or contraindicated).\n\nExclusion Criteria:\n\n* Participants unable to provide informed, voluntary decision to participate in research study as determined by the investigator. (Exclude participants who necessitate the involvement of a legally authorized representative.)\n* Terminal condition with life expectancy less than 6 months as determined by investigator.\n* Participants with cardiac tamponade or constrictive pericarditis.\n* Participants with left ventricular assistance device (LVAD device) or had a cardiac transplantation or listed for transplantation.\n* Implantation of a CRT (cardiac resynchronization therapy) device during index hospitalization or intent to implant a CRT device.\n* Presence of hemodynamically significant mitral and/or aortic valve disease, except mitral regurgitation secondary to left ventricular dilatation, as determined by investigator.\n* Presence of hemodynamically significant obstructive lesions of left ventricular outflow tract, including aortic and sub-aortic stenosis, as determined by investigator.\n* Severe primary pulmonary, renal or hepatic disease, as determined by investigator.\n* Women of childbearing age (Age \\<50).\n* History of pulmonary embolism of less than 3 months.\n* Dialysis dependent or dialysis initiation expected within three months.\n* Chronic home IV therapy or cardiac inotropes or diuretics.\n* Physical deformity in the chest area or lesion that may prevent proper HEMOTAG application or adjustment.\n* Illness/ Condition which may be aggravated or cause significant discomfort by the application of the HEMOTAG (skin issues, e.g. Intolerance to use of skin electrodes).\n* Impaired cognitive ability or any other state that may prevent full compliance with the study protocol, according to investigator's assessment.\n* Congenital heart malformations (Complex, or uncorrected congenital heart disease).\n* Participant enrolled in another interventional study (observational or registries are not excluded).\n* Participant HF is managed remotely with another monitoring device or program (for example: Pulmonary/ Lt Atrial pressure monitoring, lung fluid monitoring. BNP/pro-BNP or bioimpedance or ICD or biventricular pacemaker with impedance monitoring will be allowed unless it is part of another research protocol).\n* Prisoners and wards of the state.\n* Inability to provide informed consent (Must speak English or Spanish or Creole).",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "22 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Cindy Kober",
                    "role": "CONTACT",
                    "phone": "561-945-9303",
                    "email": "cindy@aventusoft.com"
                },
                {
                    "name": "Kaustubh Kale",
                    "role": "CONTACT",
                    "phone": "954-399-3335",
                    "email": "kaustubh@aventusoft.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "David Snipelisky, MD",
                    "affiliation": "Cleveland Clinic Florida",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Cleveland Clinic Florida",
                    "status": "RECRUITING",
                    "city": "Weston",
                    "state": "Florida",
                    "zip": "33331",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Diana Yanez, BSN,RN",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Cecilia Calvo",
                            "role": "CONTACT"
                        },
                        {
                            "name": "David Snipelisky",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.10037,
                        "lon": -80.39977
                    }
                },
                {
                    "facility": "Baylor Scott & White Research Institute",
                    "status": "RECRUITING",
                    "city": "Temple",
                    "state": "Texas",
                    "zip": "76508",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Amy M Watts, BSN,RN",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Jamie Hernandez-Montfort, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.09823,
                        "lon": -97.34278
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006333",
                    "term": "Heart Failure"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9421",
                    "name": "Heart Failure",
                    "asFound": "Heart Failure",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}